How to buy Edwards Lifesciences (EW) shares in Australia
Learn how to easily invest in Edwards Lifesciences shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Edwards Lifesciences Corp (EW) is a leading medical devices business with stocks listed in the US. It opened the day at US$95.29 after a previous close of US$95.09. During the day the price has varied from a low of USD94.88 to a high of USD97.7. The latest price was USD97.45 (25 minute delay). Edwards Lifesciences is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Edwards Lifesciences
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Edwards Lifesciences. Find the share by name or ticker symbol: EW. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Edwards Lifesciences reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$95.09, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Edwards Lifesciences, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Edwards Lifesciences. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Edwards Lifesciences key stats
- Compare share trading platforms
- Is Edwards Lifesciences stock a buy or sell?
- Edwards Lifesciences performance over time
- Is Edwards Lifesciences suitable for ethical investing?
- Are Edwards Lifesciences shares over-valued?
- Edwards Lifesciences's financials
- How volatile are Edwards Lifesciences shares?
- Does Edwards Lifesciences pay a dividend?
- Have Edwards Lifesciences shares ever split?
- Other common questions
Edwards Lifesciences stock price (NYSE:EW)Use our graph to track the performance of EW stocks over time.
Edwards Lifesciences shares at a glance
|52-week range||US$85.58 - US$131.73|
|50-day moving average||US$99.1768|
|200-day moving average||US$111.2752|
|Dividend yield||US$0 (0%)|
|Earnings per share (TTM)||US$2.43|
Compare trading apps to buy Edwards Lifesciences shares
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Edwards Lifesciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Edwards Lifesciences price performance over time
|1 week (2022-06-23)||4.09%|
|1 month (2022-06-03)||0.74%|
|3 months (2022-03-30)||-16.77%|
|1 year (2021-07-02)||-8.57%|
|2 years (2020-07-02)||40.84%|
|3 years (2019-07-03)||56.00%|
|5 years (2017-07-03)||147.73%|
Stocks similar to Edwards Lifesciences
Is Edwards Lifesciences under- or over-valued?
Valuing Edwards Lifesciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Edwards Lifesciences's P/E ratio
Edwards Lifesciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, Edwards Lifesciences shares trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Edwards Lifesciences's PEG ratio
Edwards Lifesciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9922. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Edwards Lifesciences's EBITDA
Edwards Lifesciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$1.8 billion (£1.5 billion).
The EBITDA is a measure of a Edwards Lifesciences's overall financial performance and is widely used to measure a its profitability.
Edwards Lifesciences financials
|Revenue TTM||US$5.4 billion|
|Operating margin TTM||30.69%|
|Gross profit TTM||US$4 billion|
|Return on assets TTM||13.15%|
|Return on equity TTM||29.3%|
|Market capitalisation||US$60.6 billion|
TTM: trailing 12 months
Edwards Lifesciences's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Edwards Lifesciences's total ESG risk score
Total ESG risk: 21.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences's overall score of 21.68 (as at 01/01/2019) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Edwards Lifesciences's environmental score
Environmental score: 4.78/100
Edwards Lifesciences's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Edwards Lifesciences's social score
Social score: 13.43/100
Edwards Lifesciences's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Edwards Lifesciences's governance score
Governance score: 10.96/100
Edwards Lifesciences's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Edwards Lifesciences's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Edwards Lifesciences scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||21.68|
|Total ESG percentile||24.1|
|Environmental score percentile||6|
|Social score percentile||6|
|Governance score percentile||6|
|Level of controversy||2|
Edwards Lifesciences share dividends
We're not expecting Edwards Lifesciences to pay a dividend over the next 12 months.
Have Edwards Lifesciences's shares ever split?
Edwards Lifesciences's shares were split on a 3:1 basis on 1 June 2020. So if you had owned 1 share the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences shares which in turn could have impacted Edwards Lifesciences's share price.
Edwards Lifesciences share price volatility
Over the last 12 months, Edwards Lifesciences's shares have ranged in value from as little as US$85.58 up to US$131.73. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences's is 1.1633. This would suggest that Edwards Lifesciences's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
Edwards Lifesciences overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Edwards Lifesciences in the news
Edwards Lifesciences (EW) Gains As Market Dips: What You Should Know
OCPNY vs. EW: Which Stock Is the Better Value Option?
Edwards Lifesciences (EW) Gains As Market Dips: What You Should Know
Frequently asked questions
More guides on Finder
How to invest in the Octava Minerals IPO
Everything we know about the Octava Minerals IPO, plus information on how to buy in.
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
Ask an Expert